Results 101 to 110 of about 15,332 (223)

Is routine screening for Candida auris necessary in ICU?

Iranian Journal of Microbiology
Background and Objectives: The capability to cause invasive infection, multi-drug resistance, and health care-associated outbreaks of Candida auris have made it a pathogen of great concern.
Arun Sachu, Harisree Sudersanan, Sanjo Sunny, Philip Mathew, Ajeesh Kumar, Alice David   +5 more
doaj   +1 more source

Epi Update for Friday, June 2, 2017 [PDF]

, 2017
Weekly Newsletter for the Center for Acute Disease Epidemiology of the Iowa Department of Public ...

core  

Multicenter Evaluation of Candida QuickFISH BC for Identification of Candida Species Directly from Blood Culture Bottles [PDF]

, 2015
Candida species are common causes of bloodstream infections (BSI), with high mortality. Four species cause >90% of Candida BSI: C. albicans, C. glabrata, C. parapsilosis, and C. tropicalis. Differentiation of Candida spp.
Abdelhamed, Ayman M., Buckner, Rebecca J., Davis, Thomas E., Fairfax, Marilynn R., Fuller, DeAnna D., Jacobs, Michael R., Lephart, Paul R., Morgan, Margie A., Poulter, Melinda D., Regi, Sarah B., Salimnia, Hossein, Watkins, Tonya, Wu, Fann, Zhang, Sean X.   +13 more
core   +1 more source

Candida auris [PDF]

Canadian Medical Association Journal, 2019
Ilan S, Schwartz, Tanis C, Dingle
openaire   +2 more sources

Evaluation of CHROMagar Candida Plus for the detection of C. auris with a panel of 206 fungal isolates and 83 colonization screening skin-swabs

Microbiology Spectrum
CHROMagar Candida Plus is a new formulation of chromogenic media designed for the detection and differentiation of major clinical Candida species, including Candida auris.
Meghan L. Bentz, Ngoc Le, Brian Min, Natalie S. Nunnally, Vickie Sullivan, Mike Tran, Shawn R. Lockhart, Ana Litvintseva, Elizabeth L. Berkow, D. Joseph Sexton   +9 more
doaj   +1 more source

Candida auris in a tertiary healthcare setting in south India: A case series [PDF]

Current Medical Mycology
Candida species can produce a variety of clinical manifestations, and several non-albicans species of Candida, including Candida auris, have been linked to the rise of invasive fungal infections with high rates of treatment failure.
Asem Ashraf, Rohan Pinto, Vimal Karnaker
doaj   +1 more source

Clin Infect Dis [PDF]

Candida auris is an emerging, multidrug-resistant yeast that can spread in healthcare settings. It can cause invasive infections with high mortality and is difficult to identify using traditional yeast identification methods.

core  

Fosmanogepix (APX001) Is Effective in the Treatment of Immunocompromised Mice Infected with Invasive Pulmonary Scedosporiosis or Disseminated Fusariosis. [PDF]

, 2020
There are limited treatment options for immunosuppressed patients with lethal invasive fungal infections due to Fusarium and Scedosporium Manogepix (MGX; APX001A) is a novel antifungal that targets the conserved Gwt1 enzyme required for localization of ...
Alkhazraji, Sondus, Alqarihi, Abdullah, Gebremariam, Teclegiorgis, Gu, Yiyou, Ibrahim, Ashraf S, Mamouei, Zeinab, Shaw, Karen J, Singh, Shakti, Wiederhold, Nathan P   +8 more
core   +1 more source

The Rise of Candida auris: a Drug-Resistant Fatal Fungus [PDF]

, 2023
Candida auris is a fungus that is creating a significant public health threat, causing severe healthcare associated infections. Commonly misidentified in laboratories, C. auris is extremely resistant to most antifungal medications. C.
Intanavong, Amber, Stier, Payton, Yang, Melina   +2 more
core   +1 more source

The diverse genomes of Candida auris

The Lancet Microbe
01 september ...
Hugh Gifford, Johanna Rhodes, Rhys A Farrer   +2 more
openaire   +4 more sources